Basis of Presentation and Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2025

Basis of Presentation and Summary of Significant Accounting Policies

Schedule of Concentration of Credit Risk in Accounts Receivable

The Company is potentially subject to concentrations of credit risk in accounts receivable as the following customer balances exceed 10% of accounts receivable in the consolidated balance sheet as June 30, 2025 and December 31, 2024.


		As of June 30, 2025								As of December 31, 2024
		Accounts Receivable				% of Total Accounts Receivable				Accounts Receivable				% of Total Accounts Receivable
Customer A		$	—				—			$	200,000				28	%
Customer B		$	2,422				0	%		$	153,469				22	%
Customer C		$	79,562				12	%		$	162,100				4	%

Schedule of Information from the Consolidated Statements of Operations and Comprehensive Loss

Select information from the consolidated statements of operations and comprehensive loss as of the three months ended June 30, 2025 and 2024 is as follows:


		Revenues								Net Loss Before Allocation to Noncontrolling Interest
		Three Months Ended June 30,								Three Months Ended June 30,
Segment		2025				2024				2025				2024
Specialist isotopes and related services		$	1,198,345			$	1,022,299			$	(8,195,975	)		$	(6,219,317	)
Nuclear fuels			—				—				(66,711,648	)			(2,852,272	)
Corporate			—				—				(249,536	)			190,147
		$	1,198,345			$	1,022,299			$	(75,157,159	)		$	(8,881,442	)

Select information from the consolidated statements of operations and comprehensive loss as of the six months ended June 30, 2025 and 2024 is as follows:


		Revenues								Net Loss Before Allocation to Noncontrolling Interest
		Six Months Ended June 30,								Six Months Ended June 30,
Segment		2025				2024				2025				2024
Specialist isotopes and related services		$	2,299,950			$	1,862,653			$	(14,585,508	)		$	(10,862,811	)
Nuclear fuels			—				—				(68,805,297	)			(4,931,279	)
Corporate			—				—				(227,786	)			(52,196	)
		$	2,299,950			$	1,862,653			$	(83,618,591	)		$	(15,846,286	)

Schedule of Liabilities Measured as Level 3 at Fair Value on a Recurring Basis

The following table provides a reconciliation of the Company’s liabilities measured as a Level 3 at fair value on a recurring basis using significant unobservable inputs:


		Convertible Notes Payable
Balance as of December 31, 2023		$	—
Fair value at issuance			26,558,143
Fair value adjustment			6,875,041
Balance as of December 31, 2024			33,433,184
Fair value adjustment			64,715,131
Balance as of June 30, 2025		$	98,148,315